Interestingly, genes with oncogenic potential, including CDC42, CDC14B, STK40, BRD3, CPNE1, and MCM3, were downregulated, whereas tumor inhibitors, including CDKN2C, CASP7, and CDKN1B, were upregulated by RBM15 depletion (Fig. 3a). This evidence concerns the gene CDKN2C and neoplasm.